epirubicin has been researched along with Bone Cancer in 107 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (2.80) | 18.7374 |
| 1990's | 38 (35.51) | 18.2507 |
| 2000's | 36 (33.64) | 29.6817 |
| 2010's | 28 (26.17) | 24.3611 |
| 2020's | 2 (1.87) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Da, LT; Guo, F; Hong, X; Lin, M; Song, K; Xu, W; Zhang, S; Zhang, X | 1 |
| Bao, Y; Gao, B; Luo, W; Meng, M; Sa, R; Yu, L; Zhang, C | 1 |
| Song, JX; Yuan, BS; Yuan, Y; Zhang, MN | 1 |
| Funakoshi, T; Hirai, I | 1 |
| Feng, GS; Qin, DA; Song, JF; Song, LP | 1 |
| Boettge, KR; De Santo, G; Paasch, C; Strik, MW | 1 |
| Chang, YJ; Chen, HA; Huang, CY; Huang, MT; Makondi, PT; Wang, JW; Wei, PL | 1 |
| Kuranishi, F; Ohno, T | 1 |
| Azama, T; Kobayashi, T; Matsuda, Y | 1 |
| Namikawa, K; Oashi, K; Omata, W; Tanaka, R; Tsutsumida, A; Yamamoto, Y; Yamazaki, N | 1 |
| Cai, L; Hu, H; Yu, L; Zhang, Y | 1 |
| Cao, J; Huang, XE; Liu, J; Lu, YY; Wu, XY | 1 |
| Colleoni, M; Iorfida, M; Montagna, E; Peccatori, F; Petralia, G; Tomasi Cont, N | 1 |
| Chi, Y; Song, Y; Wang, J; Yang, L; Zhou, A | 1 |
| Bai, B; Cui, Y; Lu, C; Luo, Z | 1 |
| Dong, YG; Jiang, XM; Li, YY; Ma, YB; Xu, G | 1 |
| Barbanti, G; Bianco, V; Brozzetti, S; De Rubertis, G; Fiaschi, AI; Francini, E; Laera, L; Miano, ST; Petrioli, R; Roviello, G | 1 |
| Baresic, T; Buonadonna, A; Canzonieri, V; Corona, G; Lara, DP; Miolo, G; Santeufemia, DA; Viel, A | 1 |
| Anzalone, AA; Cajozzo, M; Fatica, F; Geraci, G; Modica, G | 1 |
| Kinoshita, S; Shimada, T; Takeyama, H; Uchida, K | 1 |
| Bassa, P; Capdevila, L; Garcia, JR; Pérez, C; Ramos, F; Valenti, V | 1 |
| Fiaschi, AI; Francini, E; Francini, G; Pascucci, A; Petrioli, R | 1 |
| Bearz, A; Berretta, M; Canzonieri, V; Ciancia, EM; Gobitti, C; Martellotta, F; Pavone, P; Taibi, R; Tirelli, U; Zanet, E | 1 |
| Berry, H; Dodwell, DJ; Gillibrand, A; Kumar, S; Perren, TJ; Velikova, G; Waters, SH | 1 |
| Cai, JY; Chen, J; Dong, L; Jiang, H; Pan, C; Shen, SH; Tang, JY; Xu, M; Xue, HL; Ye, QD; Zhou, M | 1 |
| Chen, W; Fang, Z; Li, F; Niu, P; Xiao, J; Xiong, W; Zhou, S | 1 |
| Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Couturier, O; Girault, S; Rousseau, C | 1 |
| Bi, WZ; Han, G; Lu, SB; Wang, DJ; Wang, Y; Zhang, L; Zhao, B | 1 |
| Botti, C; Carpino, A; Colucci, G; Di Lauro, L; Filippelli, G; Giannarelli, D; Giotta, F; Latorre, A; Lopez, M; Perri, P; Pizzuti, L; Sergi, D; Vici, P; Vizza, E | 1 |
| Blijham, GH; Erdkamp, FL; Knibbeler-van Rossum, CT; Lalisang, RI; Loosveld, OJ; Nortier, JW; Rodenburg, CJ; Schouten, HC; Slee, PH; Smals, AE; Tjan-Heijnen, VC; van Bochove, A; Voest, EE; Wals, J; Wils, JA | 1 |
| Cui, Q; Li, D; Liu, C; Liu, S; Liu, Y; Wang, X; Zeng, Y | 1 |
| Liu, ZL; Shu, Y; Wang, G; Yin, QS; Zhou, Y; Zou, PA | 1 |
| Chang, WL; Chao, TC; Gau, JP; Liu, YC | 1 |
| Hassali, MA; Hassan, BA; Othman, SB; Weiderpass, E; Yusoff, ZB | 1 |
| Andreesen, R; Bodenstein, H; Clemens, M; Fehnle, K; Fischer, JT; Heidemann, E; Hirschmann, WD; Kaufmann, M; König, M; Mahlke, M; Oberhoff, C; Scharl, A; Schulze, M; Souchon, R; Stoeger, H | 1 |
| Bighin, C; Colozza, MA; Contu, A; Del Mastro, L; Durando, A; Garrone, O; Genta, F; Lambiase, A; Stevani, I; Venturini, M | 1 |
| Fischer, E; Kono Kono, JO; Lanzl, I | 1 |
| Amdur, RJ; Hinerman, RW; Mendenhall, WM; Monroe, AT; Morris, CG | 1 |
| Brodak, M; Louda, M; Moravek, P; Odrazka, K; Petera, J; Prosvic, P; Rydel, L; Simakova, E; Vaculikova, M; Veselsky, Z; Zoul, Z | 1 |
| Bighin, C; Del Mastro, L; Lunardi, G; Schettini, G; Stevani, I; Vannozzi, MO; Venturini, M | 1 |
| Chang, TT; Chang, WH; Chen, RL; Hsiao, TC; Hung, IJ; Lin, DT; Lin, KH; Lin, KS; Lin, MT; Lu, MY; Shu, SG; Wu, CT; Yang, CP; Yang, RS | 1 |
| Birtle, AJ; Harland, SJ; Newby, JC | 1 |
| Andreadis, C; Charalampidou, M; Chouchos, N; Diamantopoulos, N; Mouratidou, D | 1 |
| Fukami, Y; Hasegawa, H; Hiromatsu, T; Itazu, K; Kawai, K; Komatsu, S; Sakamoto, E; Tabata, T | 1 |
| Edgren, M; Ginman, C; Kälkner, KM; Nilsson, S; Nordström, B; Ryberg, M; Strang, P; Westlin, JE; Zimmermann, R | 1 |
| Ceylaner, B; Dervişoğlu, S; Dinçbaş, FO; Hiz, M; Koca, S; Mandel, NM; Oksüz, DC; Seçmezacar, H; Uzel, B | 1 |
| Nakahara, K; Ogino, T; Osanai, T; Tsuchiya, T | 1 |
| Bighin, C; Cappuzzo, F; Del Mastro, L; Durando, A; Lambiase, A; Monfardini, S; Nicoletto, O; Olmeo, N; Puglisi, F; Venturini, M | 1 |
| Almeida, MT; Alves, MT; Borsato, ML; Brunetto, AL; Bruniera, P; Camargo, OP; Consentino, E; Davi, A; de Camargo, B; dos Santos, TM; Filho, VO; Jesus-Garcia, R; Macedo, CR; Mendes, WL; Oliveira, CR; Ortega, J; Pena, W; Péricles, P; Petrilli, AS; Prospero, JD | 1 |
| Budman, DR; Calabro, A | 1 |
| Daoud, J; Drira, MM; Frikha, M; Ghorbel, A; Karray, H; Khanfir, A | 1 |
| Kimura, M; Kobayashi, T; Miyazaki, K; Nishikawa, H; Ogawa, S; Shiku, H; Tawara, I; Ueno, S; Yamaguchi, M | 1 |
| Blanc-Fournier, C; Chasle, J; Guedin, P; Lacroix, J | 1 |
| Suzuki, M | 1 |
| Al Harbi, T; Al-Faris, N; Doyle, J; Gassas, A; Goia, C; Pappo, A | 1 |
| Giommoni, E; Grifoni, R; Mercatelli, A; Neri, B; Pantaleo, P; Pantalone, D; Paoletti, C; Rotella, V; Taddei, A; Tonelli, P | 1 |
| Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB | 1 |
| Brock, CS; Eccles, S; Francis, N; Lim, A; McLean, SR; Nathan, M; Palmieri, C; Shousha, S | 1 |
| Couban, S; Crump, M; Dancey, J; Girouard, C; Gluck, S; Kirkbride, P; Levine, M; Marlin, S; O'Reilly, S; Pritchard, KI; Shepherd, L; Shore, T; Stewart, D; Tu, D | 1 |
| Doi, Y; Endo, Y; Ishizuka, S; Kai, K; Matsumoto, Y; Morikawa, T; Nabeyama, A; Nagahiro, I; Nakashima, A; Nobuhisa, T; Sato, S; Watanabe, T; Yamada, T; Yoshida, K | 1 |
| Atalar, AC; Basaran, M; Bavbek, ES; Bilgic, B; Eralp, L; Onat, H; Ozger, H; Saglam, S; Sakar, B | 1 |
| Alvarez, A; Dirix, L; Dumez, H; Latz, J; Melemed, A; Oliveira, CT; Paridaens, R; Prové, A; Simms, L; Wildiers, H | 1 |
| Andersen, J; Bergh, J; Bjerregaard, B; Cold, S; Edlund, P; Ejlertsen, B; Ewertz, M; Jensen, MB; Kamby, C; Kristensen, B; Lindman, H; Mouridsen, HT; Nordenskjöld, B | 1 |
| Igawa, M; Kadena, H; Ueda, M; Usui, T | 1 |
| Aitini, E; Bajetta, E; Biganzoli, L; Bochicchio, AM; Buzzoni, R; Comella, G; D'Aprile, M; Di Leo, A; Nolè, F; Veltri, E | 1 |
| Arai, Y; Kakehi, Y; Kanba, T; Shichiri, Y; Yoshida, O; Yoshida, S | 1 |
| Blomqvist, C; Franssila, K; Hietanen, P; Niskanen, E; Nordling, S; Wasenius, VM | 1 |
| Kikkawa, N; Kobayashi, K; Mishima, H; Nakagawa, H; Shin, E; Takatsuka, Y; Tamaki, Y; Tono, T; Yagyu, T | 1 |
| Fujisawa, J; Satoh, Y; Uchino, J; Une, Y | 1 |
| Kanetake, H; Minami, Y; Saito, Y; Sakai, H | 1 |
| Leliefeld, H; Peulen, G; Smeets, J; Wils, J | 1 |
| Pochanugool, L; Sirikulchayanonta, V; Subhadrabandhu, T | 1 |
| Ishikawa, A; Ito, K; Matsuda, M; Matsuura, M; Nakajima, N; Ozawa, M; Suzuki, K; Toyama, K | 1 |
| Delanian, S; Housset, M; Marie, JP; Maulard, C | 1 |
| Aoyagi, H; Horiguchi, J; Iino, Y; Ishida, T; Maemura, M; Morishita, Y; Sugamata, N; Takai, Y; Yokoe, T | 1 |
| Albanese, E; Barisone, A; Canavese, G; Cantoni, E; Palumbo, R; Reggiardo, G; Rosso, R; Santi, L; Toma, S | 1 |
| Fujinaga, H; Kume, K; Matsuzaka, T; Ono, E; Wakasugi, K; Yano, M | 1 |
| Aquino, A; Cintorino, M; Francini, G; Manganelli, A; Marsili, S; Mondillo, S; Petrioli, R | 1 |
| Ogawa, Y; Ogoshi, S; Ohmori, Y; Okazaki, Y; Tanaka, Y; Toki, T | 1 |
| Barrantes, JC; García, I; Lobo-Sanahuja, F; Santamaría, S | 1 |
| Fridrik, M; Hausmaninger, H; Hehenwarter, W; Lehnert, M; Manfreda, D; Samonigg, H; Schiller, L; Sevelda, P; Steger, G; Tschurtschenthaler, G | 1 |
| Biganzoli, L; Caraci, P; Gebbia, V; Iirillo, A; Maiorino, L | 1 |
| Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R; Wenger, M | 1 |
| Leo, E; Lindemann, A; Schlegel, PG | 1 |
| Du Bois, A; Hecker, D; Köhler, G; Lisboa, B; Lück, HJ; Thomssen, C; Untch, M | 1 |
| Kokawa, Y; Oura, S; Sakurai, T; Tamaki, T; Umemura, T; Yoshimura, G | 1 |
| Ayabe, H; Hara, S; Hashizume, S; Itoyanagi, N; Oka, T; Shinguu, H; Tagawa, Y; Tooyama, H; Tou, K; Tsuji, H; Yamamoto, S; Yamazumi, K | 1 |
| Dai, G; Liu, C; Zhang, X | 1 |
| Adachi, I; Kanda, K; Murai, H; Ogita, M; Saeki, T; Sano, M; Sasaki, Y; Shimoyama, M; Tabei, T; Takashima, S; Watanabe, T | 1 |
| Etoh, Y; Imamura, H; Kamio, T; Nogami, T; Nomura, H; Saeki, T; Sakai, K; Suko, H; Suko, S; Tokunaga, H | 1 |
| Heidenreich, A | 1 |
| Bacci, G; Bertoni, F; Briccoli, A; Campanacci, M; Cesari, M; Fabbri, N; Ferrari, S; Forni, C; Gasbarrini, A; Mercuri, M | 1 |
| Fujitake, S; Kataoka, S; Maeda, Y; Nozaki, H; Shimizu, M; Tohyama, M | 1 |
| Idezuki, Y; Ishizuka, N; Kobayashi, M; Murata, N; Suwata, J; Takada, S | 1 |
| Azama, T; Furukawa, J; Katsumoto, Y; Morimoto, T; Nakaguchi, K; Okajima, S; Shingai, T; Sue, F; Yoshioka, S | 1 |
| Dai, A; Feng, J; Zheng, X | 1 |
| Esumi, K; Furukawa, H; Hashimoto, K; Ikeda, M; Imamura, H; Inoue, Y; Ishida, H; Kawasaki, T; Makino, S; Masutani, S; Miya, A; Ohta, H; Satomi, T; Tatsuta, M; Tsuda, K | 1 |
| Fukuda, Y; Hirao, S; Kinoshita, H; Koyama, I; Mayumi, K; Takatori, H; Terakura, M; Tsukazaki, Y | 1 |
| Kawahara, H; Sakurai, T; Tatematsu, H; Yamamoto, T; Yamataka, K | 1 |
| Fujii, S | 1 |
| Delaere, KP; Leliefeld, H; Peulen, F; Smeets, J; Stapper, EW; Wils, J | 1 |
| Hathirat, P; Nontasut, S; Pochanugool, L; Ratanatharathorn, V; Sirikulchayanonta, V; Subhadharaphandou, T; Yuktanonda, P | 1 |
| Hartlapp, J; Heidemann, E; Hossfeld, D; Kunz, S; Neeser, E; Possinger, K; Schumacher, K; Steinke, B; von Ingersleben, G; Waldmann, R | 1 |
| Cassidy, J; Rankin, EM | 1 |
| Bartalucci, S; Cecchettin, M; Gemelli, MT; Giorgi, F; Neri, B; Pacini, P | 1 |
| Frederiksen, PL; Oxholm, A; Oxholm, P | 1 |
3 review(s) available for epirubicin and Bone Cancer
| Article | Year |
|---|---|
The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment; Survival Analysis; Treatment Outcome | 2008 |
Leiomyosarcoma of the parotid gland in an HIV-positive patient: therapeutic approach, clinical course and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Epirubicin; Fatal Outcome; Female; HIV Infections; Humans; Ifosfamide; Immunohistochemistry; Leiomyosarcoma; Lung Neoplasms; Lymphatic Metastasis; Parotid Neoplasms; Radiotherapy | 2009 |
De novo CD5-positive diffuse large B-cell lymphoma of the temporal bone presenting with an external auditory canal tumor.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Neoplasms; CD5 Antigens; Cyclophosphamide; Ear Canal; Ear Neoplasms; Epirubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Temporal Bone; Vincristine | 2006 |
36 trial(s) available for epirubicin and Bone Cancer
| Article | Year |
|---|---|
Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience.
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Survival Analysis; Taxoids; Treatment Outcome | 2015 |
Results of RS-99 protocol for childhood solid tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prognosis; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Sarcoma, Ewing; Tamoxifen; Vincristine | 2010 |
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Polyethylene Glycols; Prospective Studies; Soft Tissue Neoplasms; Vinblastine; Vinorelbine; Viscera | 2011 |
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel; Survival Rate; Treatment Outcome; Young Adult | 2011 |
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Germany; Humans; Liver Neoplasms; Logistic Models; Lung Neoplasms; Middle Aged; Mitoxantrone; Neoplasm Staging; Probability; Proportional Hazards Models; Quality of Life; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Survival Analysis; Treatment Outcome | 2002 |
Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Paclitaxel; Taxoids; Treatment Outcome | 2003 |
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dexamethasone; Drug Administration Schedule; Epirubicin; Etoposide; Hormone Antagonists; Humans; Male; Middle Aged; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome | 2003 |
Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Staging; Probability; Prospective Studies; Receptor, ErbB-2; Risk Assessment; Soft Tissue Neoplasms; Statistics, Nonparametric; Survival Rate; Trastuzumab; Treatment Outcome | 2003 |
Unstratified chemotherapy for non-metastatic osteosarcoma of the extremities in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Extremities; Female; Humans; Male; Methotrexate; Osteosarcoma; Statistics, Nonparametric; Survival Analysis; Taiwan; Treatment Outcome | 2003 |
Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Double-Blind Method; Epirubicin; Fluorouracil; Humans; Male; Mitomycin; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Severity of Illness Index; Strontium; Treatment Outcome | 2005 |
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Docetaxel; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Receptor, ErbB-2; Taxoids; Trastuzumab | 2006 |
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival.
Topics: Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brazil; Carboplatin; Chemotherapy, Adjuvant; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Limb Salvage; Lung Neoplasms; Male; Methotrexate; Multivariate Analysis; Orthopedic Procedures; Osteosarcoma; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome | 2006 |
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prognosis; Survival Rate | 2007 |
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis; Tegafur; Time Factors; Treatment Outcome; Uracil | 2007 |
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Quality of Life; Treatment Outcome | 2008 |
A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Epirubicin; Extremities; Female; Humans; Ifosfamide; Male; Osteosarcoma; Treatment Outcome | 2007 |
Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Glutamates; Guanine; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Pemetrexed; Treatment Outcome | 2007 |
Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Pamidronate | 2008 |
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Recombinant Proteins; Tomography, X-Ray Computed; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine; World Health Organization | 1994 |
Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology Group.
Topics: Aged; Ambulatory Care; Bone Neoplasms; Drug Synergism; Drug Therapy, Combination; Epirubicin; Heart Failure; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Survival Analysis | 1995 |
Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; DNA, Neoplasm; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Ploidies; Predictive Value of Tests; S Phase; Soft Tissue Neoplasms | 1995 |
[Neoadjuvant intra-arterial infusion chemotherapy for the treatment of locally advanced breast cancer with remote metastases].
Topics: Aged; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Mastectomy, Radical; Middle Aged | 1994 |
Chemo-endocrine therapy for prostate cancer with bone metastasis. Nagasaki Prostate Cancer Research Group.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Epirubicin; Ethinyl Estradiol; Fluorouracil; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Orchiectomy; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Survival Rate; Tegafur; Uracil | 1994 |
Phase II study of orchiectomy combined with epirubicin as first-line treatment in advanced prostate carcinoma.
Topics: Aged; Bone Neoplasms; Combined Modality Therapy; Epirubicin; Follow-Up Studies; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Soft Tissue Neoplasms | 1994 |
Update of osteosarcoma in Ramathibodi, Thailand.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Epirubicin; Humans; Osteosarcoma; Radioisotope Teletherapy; Survival Rate; Thailand; Treatment Outcome | 1993 |
Weekly chemotherapy in advanced prostatic cancer.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Bone Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Humans; Male; Middle Aged; Osteoblasts; Prostatic Neoplasms | 1993 |
Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Digestive System Neoplasms; Epirubicin; Female; Humans; Middle Aged; Mitoxantrone; Remission Induction; Soft Tissue Neoplasms; Survival Analysis; Vindesine | 1995 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Middle Aged; Palliative Care; Pneumonectomy; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 1997 |
Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lung Neoplasms; Middle Aged; Paclitaxel; Pleural Neoplasms; Treatment Outcome; Ventricular Function, Left | 1997 |
A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neutropenia; Prospective Studies; Receptors, Estrogen; Recombinant Proteins; Survival Rate; Thrombocytopenia | 1997 |
[Treatment of hormone-refractive prostatic carcinoma with painful bone metastasis. Epirubicin vs. clodronate vs. epirubicin plus clodronate].
Topics: Analgesics, Non-Narcotic; Antibiotics, Antineoplastic; Bone Neoplasms; Clodronic Acid; Drug Resistance, Neoplasm; Epirubicin; Humans; Male; Pain; Prospective Studies; Prostatic Neoplasms | 1997 |
Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Extremities; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis | 1998 |
[CBDCA, etoposide and epirubicin high-dose combination chemotherapy supported by peripheral blood stem cell transplantation (PBSCT) in metastatic breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local | 1999 |
Phase II study of epirubicin in advanced hormone-resistant prostatic carcinoma.
Topics: Aged; Alopecia; Bone Neoplasms; Drug Resistance; Epirubicin; Humans; Male; Middle Aged; Prostatic Neoplasms; Time Factors | 1992 |
A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. The French Epirubicin Study Group.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Heart Failure; Hematologic Diseases; Humans; Middle Aged; Nausea; Prospective Studies; Survival Rate | 1991 |
Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitoxantrone; Quality of Life; Randomized Controlled Trials as Topic; Survival Rate | 1990 |
68 other study(ies) available for epirubicin and Bone Cancer
| Article | Year |
|---|---|
Legumain inhibitor prevents breast cancer bone metastasis by attenuating osteoclast differentiation and function.
Topics: Animals; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Epirubicin; Female; Mice; Neoplasm Metastasis; Osteoclasts | 2023 |
miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in Osteosarcoma.
Topics: Antibiotics, Antineoplastic; Apoptosis; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Epirubicin; Flow Cytometry; Humans; Intracellular Signaling Peptides and Proteins; MicroRNAs; Osteosarcoma; Real-Time Polymerase Chain Reaction; Up-Regulation | 2019 |
A multiple drug loaded, functionalized pH-sensitive nanocarrier as therapeutic and epigenetic modulator for osteosarcoma.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Deoxycytidine; Drug Combinations; Epigenesis, Genetic; Epirubicin; Gemcitabine; Hydrogen-Ion Concentration; Male; Nanocapsules; Osteosarcoma; Particle Size; Rats; Rats, Sprague-Dawley | 2020 |
Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Administration Schedule; Epirubicin; Genital Neoplasms, Male; Groin; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Paclitaxel; Paget Disease, Extramammary; Scrotum; Skin Neoplasms; Treatment Outcome | 2017 |
Integrated approach to pain management for a patient with multiple bone metastases of uterine cervical cancer.
Topics: Bone Neoplasms; Epirubicin; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pain Management; Postoperative Care; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
Mesenchymal chondrosarcoma metastasising to the pancreas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cholangiopancreatography, Endoscopic Retrograde; Chondrosarcoma, Mesenchymal; Common Bile Duct; Epirubicin; Humans; Ifosfamide; Ilium; Jaundice, Obstructive; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms; Radiotherapy, Adjuvant; Ribs; Sacrum; Spinal Fusion; Spinal Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed | 2018 |
Glucose-Regulated Protein 94 Modulates the Response of Osteosarcoma to Chemotherapy.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Epirubicin; Gemcitabine; Humans; Membrane Glycoproteins; Osteosarcoma; Paclitaxel | 2019 |
Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case report.
Topics: Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Bone Neoplasms; Breast Neoplasms; Cancer Vaccines; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Diphosphonates; Epirubicin; Female; Fixatives; Fluorouracil; Formaldehyde; Humans; Imidazoles; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prognosis; Radiotherapy Dosage; Tomography, Emission-Computed, Single-Photon; Triazoles; Zoledronic Acid | 2013 |
[A case of a patient with breast cancer, diagnosed from sternal metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Bridged-Ring Compounds; Carcinoma, Ductal, Breast; Chemoradiotherapy; Cyclophosphamide; Epirubicin; Female; Humans; Mastectomy, Segmental; Neoplasm Staging; Sternum; Taxoids | 2013 |
Combination chemotherapy for metastatic extramammary Paget disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Genital Neoplasms, Male; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paget Disease, Extramammary; Retrospective Studies; Treatment Outcome; Vincristine; Vulvar Neoplasms | 2014 |
Experiments and synthesis of bone-targeting epirubicin with the water-soluble macromolecular drug delivery systems of oxidized-dextran.
Topics: Antibiotics, Antineoplastic; Apoptosis; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Dextrans; Diphosphonates; Drug Carriers; Epirubicin; Femur; Humans; Molecular Structure; Osteosarcoma; Solubility; Water | 2014 |
Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Deoxycytidine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Retrospective Studies; Sarcoma; Survival Rate; Young Adult | 2013 |
Whole-body magnetic resonance imaging, metastatic breast cancer and pregnancy: a case report.
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Epirubicin; Female; Humans; Labor, Induced; Magnetic Resonance Imaging; Mastectomy, Modified Radical; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Radiotherapy; Tamoxifen; Treatment Outcome; Whole Body Imaging | 2014 |
[Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Thrombocytopenia; Urinary Bladder Neoplasms; Urothelium | 2014 |
[Feasibility analysis of endostatin combined with chemotherapy in the treatment of metastatic angiosarcoma].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Endostatins; Epirubicin; Feasibility Studies; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Pubic Bone; Taxoids | 2014 |
Ifosfamide-containing regimens for treating patients with osteosarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Epirubicin; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Survival Rate | 2014 |
Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Neoplasms; BRCA2 Protein; Dioxoles; Endometrial Neoplasms; Epirubicin; Female; Genes, BRCA2; Germ-Line Mutation; Humans; Ifosfamide; Liver Neoplasms; Middle Aged; Mutation, Missense; Sarcoma, Endometrial Stromal; Tetrahydroisoquinolines; Trabectedin | 2016 |
Surgical treatment of solitary sternal metastasis from breast cancer Case report.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fractures, Spontaneous; Humans; Middle Aged; Myocutaneous Flap; Pleura; Sternum | 2016 |
Usefulness of CTC and DTC-BM Detection for Adjuvant Therapy Effects and Prognosis Prediction in Early Breast Carcinoma: Results of 8-11 Years of Follow-up Evaluation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Carcinoma; Cell Count; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Liver Neoplasms; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Prognosis; Tamoxifen; Treatment Outcome | 2017 |
18F-FDG PET/CT in the Staging and Management of Breast Cancer: Value in Disease Outcome and Planning Therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Axilla; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Diphosphonates; Docetaxel; Epirubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Letrozole; Lymph Node Excision; Lymph Nodes; Mastectomy; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy; Ribs; Taxoids; Triazoles; Zoledronic Acid | 2017 |
Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Staging; Prognosis; Soft Tissue Neoplasms; Survival Rate; Taxoids; Treatment Outcome; Young Adult | 2009 |
Isolation and identification of cancer stem cells from human osteosarcom by serum-free three-dimensional culture combined with anticancer drugs.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Culture Techniques; Cell Separation; Cells, Cultured; Culture Media, Serum-Free; Epirubicin; Humans; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Octamer Transcription Factor-3; Osteosarcoma | 2010 |
Bone metastasis of a breast cancer detected by 3'-deoxy-3'-18F-fluorothymidine PET/CT.
Topics: Adult; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Dideoxynucleosides; Docetaxel; Epirubicin; Female; Humans; Positron-Emission Tomography; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Magnetic resonance imaging is appropriate for determining the osteotomy plane for appendicular osteosarcoma after neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Osteotomy; Preoperative Care; Prognosis; Prospective Studies; Surgery, Computer-Assisted; Survival Rate; Young Adult | 2012 |
Chemotherapy response analysis for osteosarcom with intra-arterial chemotherapy by subcutaneous implantable delivery system.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Extremities; Female; Follow-Up Studies; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Subcutaneous; Male; Neoadjuvant Therapy; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult | 2011 |
Enhanced antitumor activity of epirubicin combined with cerulenin in osteosarcoma.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cerulenin; Drug Synergism; Epirubicin; Fatty Acid Synthases; Male; Mice; Mice, Nude; Osteosarcoma; Transplantation, Heterologous | 2012 |
Primary bone lymphoma of the shoulder.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Diabetes Mellitus, Type 2; Epirubicin; Female; Humans; Humerus; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Middle Aged; Osteolysis; Prednisolone; Radiography; Rituximab; Vincristine | 2012 |
Impact of chemotherapy on hypercalcemia in breast and lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Calcium; Chi-Square Distribution; Cisplatin; Cyclophosphamide; Deoxycytidine; Diphosphonates; Docetaxel; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Hypercalcemia; Imidazoles; Linear Models; Logistic Models; Lung Neoplasms; Male; Middle Aged; Pamidronate; Parathyroid Hormone-Related Protein; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Taxoids; Young Adult; Zoledronic Acid | 2012 |
[Tumour of the choroid with yellowish subretinal deposits].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Bone Neoplasms; Breast Neoplasms; Choroid Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Ophthalmoscopy; Time Factors; Ultrasonography; Visual Acuity | 2003 |
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blindness; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cytarabine; Epirubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasal Cavity; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Salvage Therapy; Spinal Cord Neoplasms; Survival Analysis | 2003 |
Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubicin; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Soft Tissue Neoplasms; Survival Rate | 2004 |
Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Diphosphonates; Epirubicin; Female; Fluorouracil; Humans; Imidazoles; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Salvage Therapy; Tamoxifen; Zoledronic Acid | 2004 |
[A case of recurrent breast cancer with multiple lung, adrenal, inferior vena cava tumor thrombus and bone metastases successfully treated with 5'-DFUR and hormonal therapy].
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Floxuridine; Follow-Up Studies; Humans; Leuprolide; Lung Neoplasms; Mastectomy, Radical; Neoplastic Cells, Circulating; Tamoxifen; Vena Cava, Inferior | 2005 |
The role of preoperative radiotherapy in nonmetastatic high-grade osteosarcoma of the extremities for limb-sparing surgery.
Topics: Adolescent; Adult; Aged; Amputation, Surgical; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Extremities; Humans; Ifosfamide; Limb Salvage; Male; Mesna; Methotrexate; Middle Aged; Osteosarcoma; Prognosis; Radiotherapy Dosage; Retrospective Studies; Survival Rate | 2005 |
Long-term prevention of skeletal complications by pamidronate in a patient with bone metastasis from endometrial carcinoma: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Carboplatin; Diphosphonates; Endometrial Neoplasms; Epirubicin; Female; Humans; Paclitaxel; Pamidronate | 2006 |
Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cytoplasm; Deoxycytidine; Diphosphonates; DNA Fragmentation; Drug Antagonism; Drug Synergism; Epirubicin; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gemcitabine; Humans; Imidazoles; Indoles; Lung Neoplasms; Male; Prostatic Neoplasms; Zoledronic Acid | 2006 |
[Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases].
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2006 |
[Breast carcinoma and bone chondrosarcoma: a new syndrome?].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Chondrosarcoma; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Mammography; Middle Aged; Phenotype; Radiography, Thoracic; Radiotherapy Dosage; Ribs; Syndrome; Taxoids; Tomography, X-Ray Computed | 2006 |
[A patient with advanced breast cancer refractory to chemotherapy accompanied by carcinomatous pleurisy and multiple bone metastasis that responded to combination therapy with high-dose toremifene and docetaxel].
Topics: Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Paclitaxel; Pleural Effusion, Malignant; Pleural Neoplasms; Quality of Life; Remission Induction; Taxoids; Toremifene | 2007 |
Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infection Control; Kaplan-Meier Estimate; Melphalan; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Postoperative Care; Retrospective Studies; Risk; Salvage Therapy; Sarcoma, Ewing; Topotecan; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Vincristine | 2007 |
Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Cyclophosphamide; Diphosphonates; Eccrine Glands; Epirubicin; Fluorouracil; Humans; Ibandronic Acid; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Radiotherapy; Sweat Gland Neoplasms; Tamoxifen; Tomography, X-Ray Computed | 2007 |
[A case of advanced breast cancer leading to DIC after chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Disseminated Intravascular Coagulation; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging | 2007 |
Intra-arterial infusion chemotherapy in combination with a biscoclaurine alkaloid, Cepharanthin, to treat bone metastasis arising from renal cell carcinoma.
Topics: Alkaloids; Angiography; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Biopsy; Bone Neoplasms; Carcinoma, Renal Cell; Epirubicin; Humans; Ilium; Injections, Intra-Arterial; Kidney Neoplasms; Male; Middle Aged; Recurrence; Tomography, X-Ray Computed; Vinblastine | 1994 |
[A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Medroxyprogesterone; Middle Aged; Tamoxifen | 1994 |
[Advanced breast cancer with onset of multi-organ metastases successfully treated with combined loco-regional therapies: a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cholestasis; Combined Modality Therapy; Drainage; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy; Middle Aged; Mitomycin; Pleural Effusion, Malignant | 1993 |
Clinical effects on CA 15-3 level of cyclosporin A as a chemosensitiser in chemoresistant metastatic breast cancer.
Topics: Adenocarcinoma; Antigens, Tumor-Associated, Carbohydrate; Bone Neoplasms; Breast Neoplasms; Cyclosporine; Drug Resistance; Epirubicin; Female; Humans; Middle Aged | 1993 |
[Combined mitoxantrone therapy for heavily pretreated metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Middle Aged; Mitoxantrone; Salvage Therapy; Skin Neoplasms | 1993 |
Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome | 1993 |
[A case of giant advanced breast cancer responding remarkably to CEFT therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Middle Aged; Neoplasm Invasiveness; Tamoxifen; Thoracic Neoplasms | 1993 |
A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Tamoxifen; Thoracic Neoplasms | 1995 |
Case report: pulmonary blastoma in children--response to chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Pulmonary Blastoma; Vincristine | 1996 |
Thyroid cancer: different outcomes to chemotherapy according to tumour histology.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Thyroid Neoplasms; Treatment Outcome | 1995 |
Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Medulloblastoma; Methotrexate; Remission Induction; Vincristine | 1997 |
[Bone metastases responsive to pamidronate therapy in breast cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intravenous; Mitomycin; Pamidronate | 1997 |
[A case of hepatic arterial infusion chemotherapy for multiple liver metastasis from breast cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy; Middle Aged; Pleural Neoplasms | 1997 |
[Chemosensitivity test for human osteosarcoma cells].
Topics: Antibiotics, Antineoplastic; Bone Neoplasms; Drug Screening Assays, Antitumor; Epirubicin; Humans; Mitomycin; Osteosarcoma; Tumor Cells, Cultured | 1996 |
[A case of complete remission of gastric endocrine cell carcinoma with multiple bone metastasis by combination chemotherapy and high-dose chemotherapy with autologous peripheral blood stem cell transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoid Tumor; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Remission Induction; Stomach Neoplasms; Vincristine | 1997 |
[A case of giant advanced breast cancer responding remarkably to chemo-endocrine therapy chiefly with doxifluridine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Floxuridine; Fluorouracil; Humans; Pleural Effusion, Malignant; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1998 |
[A case of multiple bone metastases from advanced breast cancer effectively treated with pamidronate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Pamidronate; Skin Neoplasms | 1999 |
[A clinical report of high-dose epirubicin combined with cyclophosphamide and fluorouracil for advanced breast cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Medullary; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging | 1998 |
[A case report of successful transcatheter arterial embolization therapy for osseous metastasis of hepatocellular carcinoma].
Topics: Aged; Antibiotics, Antineoplastic; Bone Neoplasms; Carcinoma, Hepatocellular; Embolization, Therapeutic; Epirubicin; Humans; Iodized Oil; Liver Neoplasms; Male; Pelvic Bones | 2000 |
[Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Female; Floxuridine; Fluorouracil; Humans; Medroxyprogesterone; Middle Aged; Progesterone Congeners; Treatment Outcome | 2001 |
[Results of treatment based on endocrine therapy for bone metastasis from breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone; Middle Aged; Palliative Care; Progesterone Congeners; Quality of Life; Survival Rate | 2001 |
[Successful treatment of adenocarcinoma of the lung with bone metastases by combined chemotherapy with epirubicin, mitomycin C and carboplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubicin; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin | 1992 |
Multidisciplinary "limb salvage" treatment of osteosarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hospitals, University; Humans; Male; Neoplasm Staging; Osteosarcoma; Radiotherapy; Survival Rate; Thailand | 1991 |
Hypersensitivity reaction to epirubicin.
Topics: Bone Neoplasms; Breast Neoplasms; Drug Hypersensitivity; Epirubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Middle Aged | 1989 |
Osteocalcin as a biological marker in the therapeutic management of breast cancer bone metastases.
Topics: Adult; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Epirubicin; Female; Humans; Middle Aged; Osteocalcin | 1989 |
Epirubicin-induced primary Sjögren's syndrome.
Topics: Adenocarcinoma; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Middle Aged; Sjogren's Syndrome | 1986 |